The subject matter disclosed herein provides a response to a dose of a substance and/or controls the administration of the dose. In one aspect, there is provided a system. The system may include a processor and at least one memory configured to provide a response determinator. The response determinator may receive therapeutic and wellness data. Moreover, the response determinator may determine a response based on the received therapeutic and wellness data. The response may represent a reaction to a substance integrated with an ingestible event marker. The determined response may be provided to, for example, a therapy controller. Related systems, methods, and articles of manufacture are also described.

Claims

13 · 2 independent · depth 2

13 granted claims

›1.independentA system comprising:na processor; andat least one memory, the processor and the at least one memory configured to provide a response determinator to:r…+5

›2.↳ 1The system of claim 1, wherein the therapeutic and wellness data includes ingestible event marker data received from the ingestible event marker integ…d2

›3.↳ 1The system of claim 1, wherein the therapeutic and wellness data includes data representative of physiological aspects associated with the ingestion o…d2

›4.↳ 1The system of claim 1, wherein the therapeutic and wellness data includes one or more of the following: an ingestion time; an identification of the su…d2

›5.↳ 1The system of claim 1, wherein the response determinator determines the response as a function of the therapeutic and wellness data.d2

›6.↳ 1The system of claim 1 further comprising:na therapy controller configured to control, based on the response, at least one of an amount the substance a…d2

›7.independentA system comprising:na processor; andat least one memory, the processor and the at least one memory configured to provide a therapy controller to: rec…+6

›8.↳ 7The system of claim 7, wherein the therapy controller uses a closed-loop to control at least one of the dose of the substance and the time of the dose…d2

›9.↳ 7The system of claim 7, wherein the therapy controller uses a closed-loop to vary an input to the response to generate an output of the response, the o…d2

›10.↳ 7The system of claim 7, wherein the ingestible event marker data are received from the ingestible event marker integrated with the substance, the inges…d2

›11.↳ 7The system of claim 7, wherein the therapeutic and wellness data represents physiological aspects associated with the ingestion of the ingestible even…d2

›12.↳ 7The system of claim 7, wherein the response is determined based on the reaction of at least one of an individual patient, a population, and a subset o…d2

›13.↳ 7The system of claim 7, wherein the response is determined as a function of the therapeutic and wellness data.d2

Classifications

8 codes

IPC · International Patent Classification

Section A — Human necessities

A61M5/168

Section G — Physics

G08B1/08

USPC · US Patent Classification

604/65340/10.1340/539.12600/302340/572.1604/66

Claim changes

Soon

Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoom

USPTOApplicanthover for detail · click to open

Pendency

3.3 y

1,203 days filing → grant

Office actions

after a restriction

Interviews

examiner interview summaries

Examiner

Quynh-Nhu H Vu

art unit 3763 · TC 3700

Law firm

Law firm · Log in to unlock

Citations: 886 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Priority chain

2 priority documents

Priority

25 Mar 2009

earliest claimed

›Priority documents — 2

Type	Document	Date
provisional	US 61163359	25 Mar 2009
related publication	US 20120022443 A1	26 Jan 2012

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.